Lf. Villagra et al., DIFFERENTIAL MECHANISMS OF MULTIDRUG-RESISTANCE ARE EXPRESSED DURING STEPWISE SELECTION OF KB-3-1 CELLS WITH ADRIAMYCIN, International journal of oncology, 11(5), 1997, pp. 1025-1033
A major limitation of cancer chemotherapy is development of resistance
. In this study, we analyzed KB-3-1 cells and adriamycin-selected mult
idrug resistant sublines KB-A1 and KB-A10 cells for mechanisms of resi
stance. KB-A10 cells are 10-fold more resistant than KB-A1 cells but h
ave lower P-glycoprotein. Of the known mechanisms of multidrug resista
nce, topoisomerase II and lung-resistance-related protein were altered
between the resistant cell lines. Glutathione-S-transferase activity
and multidrug-resistance-related protein levels were higher in the res
istant cell lines compared to the sensitive cells but were similar in
KB-A1 and KB-A10 cells. Results indicate differential regulation of me
chanisms of resistance with stepwise selection.